Randomized Controlled Trial of a Novel Communication Device Assessed During Noninvasive Ventilation Therapy.

ABSTRACT:

Background

Noninvasive ventilation (NIV), a form of positive airway pressure (PAP) therapy, is the standard of care for various forms of acute respiratory failure (ARF). Communication impairment is a side effect of NIV, impedes patient care, contributes to distress and intolerance, and potentially increases intubation rates. This study aimed to evaluate communication impairment during CPAP therapy and demonstrate communication device improvement with a standardized protocol.

Research question

How does an oronasal mask affect communication intelligibility? How does use of an NIV communication device change this communication intelligibility?

Study design and methods

A single-center randomized controlled trial (36 outpatients with OSA on CPAP therapy) assessed exposure

SUBMITTER: Wong AI 

PROVIDER: S-EPMC8039010 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature